Global iminodiacetonitrile (IDAN, CAS 628-87-5) market is anticipated to grow at a CAGR of 3.4% by 2023, according to a new report published by Gen Consulting Company. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).
The Global Market for iminodiacetonitrile (IDAN, CAS 628-87-5) to 2023 offers detailed coverage of iminodiacetonitrile industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading iminodiacetonitrile producers to provide exhaustive coverage of the iminodiacetonitrile.
Report contents include
- Analysis of the iminodiacetonitrile market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on iminodiacetonitrile including products, sales/revenues, and market position
- Market structure, market drivers and restraints.
Key regions
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South America
Key Vendors
- Chongqing Ziguang Chemical Co., Ltd.
- Guang'an Chengxin Chemical Co., Ltd
- request free sample to get a complete list of companies
Part 1. Summary
Part 2. Report Methodology
2.1 Methodology
2.2 Data Source
2.3 Disclaimer
Part 3. Market Overview
3.1 General Information
3.2 Segmentation by Application
3.2.1 Overview
3.2.2 Chinese Iminodiacetonitrile Market by Application
3.3 Regional Iminodiacetonitrile Market Size (Status & Prospect)
Part 4. Competitive Landscape
4.1 Chinese Iminodiacetonitrile Sales & Share by Company (2013-2018)
4.2 Chinese Iminodiacetonitrile Revenue & Share by Company (2013-2018)
4.3 Price Trends
4.4 Competitive Trends
Part 5. Segmentation by Application
5.1 Chinese Iminodiacetonitrile Sales Volume by Application (2013-2018)
5.2 Chinese Iminodiacetonitrile Revenue by Application (2013-2018)
5.3 Chinese Iminodiacetonitrile Price by Application (2013-2018)
Part 6. Regional Perspectives
6.1 North China
6.2 Northeast China
6.3 East China
6.4 South Central China
6.5 Southwest China
6.6 Northwest China
Part 7. Company Profiles
7.1 Company Profile
7.2 Product Offered
7.3 Business Performance (2013-2018)
Part 8. Market Forecast
8.1 Chinese Iminodiacetonitrile Market Size Forecast (2018-2023)
8.1.1 Chinese Iminodiacetonitrile Sales Forecast (2018-2023)
8.1.2 Chinese Iminodiacetonitrile Revenue Forecast (2018-2023)
8.2 Forecast by Region
8.3 Forecast by Application
Part 9. Industry Value Chain
9.1 Iminodiacetonitrile Industry Value Chain Analysis
9.2 Upstream Raw Materials
9.3 End-users & Customers
9.4 Distributors
Part 10. Market Drivers
10.1 Rising Demand
10.2 Entry Barrier
10.3 Economic/Political Environmental
Electroceuticals are gaining attention as a non-invasive neuromodulation method with the advantages of low risk and low cost, replacing risky and costly invasive brain stimulation. In particular, it is expected to be a safe and effective treatment for treatment-resistant patients who have adverse re...
As of 2022, the total market size of intraocular lenses in Korea is estimated to be approximately ***units (***USD) by manufacturers'/importers' initial selling unit and ***units (***USD) by medical institutions' purchase unit.
It is estimated that the relatively high production/import volume...
In this report, medical AI is defined as artificial intelligence used across the healthcare industry. AI-enabled medical devices are in particular referred to devices which assist healthcare providers in diagnosing, managing and/or predicting diseases through analyzing medical big data with artifici...
The new DRG is a mixed payment method in which the NHIS pays for medical expenses incurred during a single medical treatment, dividing the cost of procedures, drugs, and therapeutic materials into all-inclusive and non-inclusive fees.
Most medical services are comprehensively bundled together...
As of 2022, the total market size of the wound dressings in Korea is estimated to be approximately USD *** million, about an increase of ***% compared to the previous year. Reimbursement volume is estimated to be approximately USD *** million - around ***% of the entire market.
Afterwards, it...
As defined by the FDA, Digital Therapeutics (DTx) is a "Software as a Medical Device (SaMD) that provides evidence-based therapeutic interventions to non-patients for the purpose of preventing, managing, or treating a medical disorder or disease based on biometric information collected from general-...
In 2022, the total market size of dental implants in Korea is estimated to be approxiamately USD ***million at manufacturers/importers' initial selling prices (about *** units, including fixtures and upper parts) and USD *** million at medical institutions' purchase prices.
The dental implants...
Dermal fillers are classified by the MFDS as Class Ⅳ medical devices, with the product classification number B04230.01 (biomaterial graft/prosthesis) or B04230.02 (graft/prosthesis).
According to the , dermal fillers are non-rei...
In 2022, the total market size of anti-adhesion products in Korea is estimated to be approximately USD *** million (manufacturers/importers' initial selling prices) and USD *** million (medical institutions' purchase prices).
While some estimates put the market size at around USD *** million ...
Executive Summary
Azoth Analytics has released a research report titled "Global EV Transmission Systems Market (2023 Edition)" which provides a complete analysis of the Global EV Transmission Systems industry in terms of market segmentation By Type (Single Speed and Multi Speed), By EV ...